The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Individualizing the starting dose for MPT therapy in elderly myeloma patients.
Gary E Blau
Consultant or Advisory Role - Purdue University (U)
Seza Orcun
No relevant relationships to disclose
Jose Miguel Lainez
No relevant relationships to disclose
Gintaras V Reklaitis
No relevant relationships to disclose
Attaya Suvannasankha
No relevant relationships to disclose
Christopher A. Fausel
No relevant relationships to disclose
Patrick Kiel
No relevant relationships to disclose
Elias J. Anaissie
No relevant relationships to disclose